Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial

被引：0
作者：
S Cillino
F Di Pace
G Cillino
A Casuccio
机构：
[1] Ophthalmology Section,Department of Experimental Biomedicine and Clinical Neuroscience
[2] University of Palermo (Italy),undefined
来源：
Eye | 2011年 / 25卷
关键词：
trabeculectomy; mitomycin-C; Ologen; adjuvants in trabeculectomy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1598 / 1606
页数：8
相关论文
共 28 条
  • [21] Frühe Bindehautatrophie nach Trabekulektomie mit Mitomycin-C-Applikation und Kollagen-Matrix-ImplantationEarly atrophy of the conjunctiva after trabeculectomy with mitomycin C and collagen matrix implant
    R. Siggel
    T. Dietlein
    Der Ophthalmologe, 2018, 115 (1): : 74 - 76
  • [22] Secondary subconjunctival implantation of a biodegradable collagen-glycosaminoglycan matrix to treat ocular hypotony following trabeculectomy with mitomycin C
    Dietlein, T. S.
    Lappas, A.
    Rosentreter, A.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (08) : 985 - 988
  • [23] Augmenting trabeculectomy in glaucoma with subconjunctival mitomycin C versus subconjunctival 5-fluorouracil: a randomized clinical trial
    Mostafaei, Ali
    CLINICAL OPHTHALMOLOGY, 2011, 5 : 491 - 494
  • [24] Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up
    Castejon, Miguel A.
    Teus, Miguel A.
    Bolivar, Gema
    Paz-Moreno-Arrones, Javier
    Castano, Beatriz
    JOURNAL OF GLAUCOMA, 2018, 27 (01) : 50 - 54
  • [25] The Short-term Effect of Subtenon Sponge Application Versus Subtenon Irrigation of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device: A Randomized Trial
    Quist, Michael S.
    Brown, Ninita
    Bicket, Amanda K.
    Herndon, Leon W.
    JOURNAL OF GLAUCOMA, 2018, 27 (02) : 148 - 156
  • [26] Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC)
    Colombo, Renzo
    Salonia, Andrea
    Leib, Zvi
    Pavone-Macaluso, Michele
    Engelstein, Dov
    BJU INTERNATIONAL, 2011, 107 (06) : 912 - 918
  • [27] CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer
    Mostafid, A. Hugh
    Porta, Nuria
    Cresswell, Joanne
    Griffiths, Thomas R. L.
    Kelly, John D.
    Penegar, Steven R.
    Davenport, Kim
    McGrath, John S.
    Campain, Nicholas
    Cooke, Peter
    Masood, Shikohe
    Knowles, Margaret A.
    Feber, Andrew
    Knight, Allen
    Catto, James W. F.
    Lewis, Rebecca
    Hall, Emma
    BJU INTERNATIONAL, 2020, 125 (06) : 817 - 826
  • [28] A comparative, randomized, contralateral study between the use of Mitomycin-C and accelerated cross-linking as adjuvant therapy after trans-epithelial all surface laser ablation for moderate to high myopia (ASLA-MMC vs. ASLA-XTRA): a pilot study
    Kymionis, George D.
    Selimis, Vasileios
    Tsoulnaras, Konstantinos, I
    Mahayni, M. H. D. Ghaith
    Aslanides, Ioannis M.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2018, 13 (04) : 245 - 250
123